Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypertension and renal insufficiency].

M Laville1

  • 1Service de néphrologie et hypertension artérielle, pavillon P, hôpital Edouard-Herriot, 69437 Lyon.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|February 24, 2001
PubMed
Summary

Controlling high blood pressure is crucial for patients with chronic kidney disease. Normalizing blood pressure, especially with angiotensin converting enzyme inhibitors, slows kidney function decline and prevents terminal renal failure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of proton beam radiation therapy on conduction of visual information as assessed by visual evoked potentials in patients with brain or head and neck tumors: A bicentric prospective study.

Journal francais d'ophtalmologie·2026
Same author

Loss of smell in lung cancer patients undergoing chemotherapy: Prevalence and relationship with food habit changes.

Lung cancer (Amsterdam, Netherlands)·2023
Same author

Bariatric surgery affects obesity-related protein requirements.

Clinical nutrition ESPEN·2020
Same author

The FiberTAG project: Tagging dietary fibre intake by measuring biomarkers related to the gut microbiota and their interest for health.

Nutrition bulletin·2020
Same author

Obesity phenotype and patient-reported outcomes in moderate and severe chronic kidney disease: a cross-sectional study from the CKD-REIN cohort study.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2019
Same author

Metformin misuse in chronic kidney disease.

Diabetes & metabolism·2018

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Context:

  • Hypertension is a common complication and cause of chronic renal failure, accelerating disease progression.
  • Vascular and ischemic renal parenchyma damage are consequences of uncontrolled hypertension leading to end-stage renal disease.
  • 10-25% of new dialysis patients are classified as hypertensive, highlighting the prevalence of vascular renal disease.

Purpose:

  • To quantify the influences of hypertension, proteinuria, and metabolic factors on renal function decline.
  • To evaluate the benefits of blood pressure normalization in diabetic and non-diabetic kidney disease.
  • To assess the role of angiotensin converting enzyme inhibitors in managing hypertensive nephropathy.

Summary:

  • Recent cohort studies and clinical trials demonstrate that normalizing blood pressure significantly benefits patients with renal disease, particularly when proteinuria is pronounced.
  • Treatment including angiotensin converting enzyme inhibitors is especially effective in slowing the degradation of renal function.
  • Elevated blood pressure, both systolic and diastolic, increases the risk of renal failure, with diastolic increases of 20 mmHg doubling creatinine increase risk.

Impact:

  • Highlights the critical role of blood pressure management in preventing progression to end-stage renal disease.
  • Emphasizes the importance of early and effective antihypertensive treatment, including ACE inhibitors, for kidney protection.
  • Provides evidence for targeted interventions in high-risk populations to mitigate renal risk associated with hypertension.

Related Experiment Videos